University of Wollongong
Browse

Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy

Download (229.85 kB)
journal contribution
posted on 2024-11-15, 21:20 authored by Raj RamakrishnaRaj Ramakrishna, Terrence H Diamond, William Alexander, Arumugam ManoharanArumugam Manoharan, Terry Golombick
Curcumin, when used in a combination regimen in multiple myeloma patients, has comparable progression-free survival without the adverse effects of steroid-based combination therapies that is curcumin may be a viable alternative to corticosteroids in combination with an immunomodulatory drug or proteasome inhibitor.

History

Citation

Ramakrishna, R., Diamond, T. H., Alexander, W., Manoharan, A. & Golombick, T. (2020). Use of Curcumin in Multiple Myeloma patients intolerant of steroid therapy. Clinical Case Reports, 8 (4), 739-744.

Language

English

RIS ID

142653

Usage metrics

    Categories

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC